Real-world evaluation of optimal medical therapy after percutaneous coronary intervention.

Real-world evaluation of optimal medical therapy after percutaneous coronary intervention. - Real-world evaluation of optimal medical therapy after percutaneous coronary intervention.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020783

Enrollment

2000

Registered

2016-01-28

Start date

2016-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent percutaneous coronary intervention in study institutions and were registered in Kumamoto Intervention Conference Study (KICS) registry and who agreed with participant in this study with consent documents

Exclusion criteria

Exclusion criteria: Patiens who did not agree or who met exclusion criteria as follows: 1) Patients without implantation of coronary stents (balloon angioplasty only) 2) With residual stenosis >50%, died during admission, critical complications such as subacute stent thrombosis during admission or patients with emergent coronary artery bypass grafting surgery 3) Others

Design outcomes

Primary

Measure	Time frame
Major adverse cardiac event (MACE), including cardiovascular death, non-fatal myocardial infarction, stroke, stent thrombosis, unstable angina and admission due to ischemic heart failure	—

Secondary

Measure	Time frame
Hemorrhagic event rates Interruption rates of medical therapy P2Y12 reaction unit Neointimal thickening Existence of coronary thrombus at follow-up time	—

Countries

Japan

Contacts

Public ContactSeiji Hokimoto

Graduate School of Medical Sciences, Kumamoto University Department of Cardiovascular Medicine

shokimot@kumamoto-u.ac.jp81-96-373-5175

Outcome results